635 related articles for article (PubMed ID: 18568538)
21. Vascular density and VEGF expression in hepatic lesions.
Brodsky SV; Mendelev N; Melamed M; Ramaswamy G
J Gastrointestin Liver Dis; 2007 Dec; 16(4):373-7. PubMed ID: 18193117
[TBL] [Abstract][Full Text] [Related]
22. [A comparative study of MRI manifestations and pathological changes in hepatocellular carcinoma treated by transcatheter arterial chemoembolization with lipiodol].
Liu R; Wang JH; Zhou KR; Yan FH; Yan ZP; Shen JZ; Tan YS; Cai Y
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):754-8. PubMed ID: 16248948
[TBL] [Abstract][Full Text] [Related]
23. Effect of transcatheter hepatic arterial embolization on angiogenesis in an animal model.
Gupta S; Kobayashi S; Phongkitkarun S; Broemeling LD; Kan Z
Invest Radiol; 2006 Jun; 41(6):516-21. PubMed ID: 16763470
[TBL] [Abstract][Full Text] [Related]
24. [Comparison between pathological findings and MR diffusion-weighted imaging in primary hepatocellular carcinoma after transcatheter arterial chemoembolization].
Xiao YP; Xiao EH; Luo JG; Bian DJ; Li MQ; He Z; Shang QL; Liang B
Zhonghua Zhong Liu Za Zhi; 2008 Dec; 30(12):914-6. PubMed ID: 19173992
[TBL] [Abstract][Full Text] [Related]
25. Necrosis and apoptosis in hepatocellular carcinoma following low-dose versus high-dose preoperative chemoembolization.
Lu W; Li YH; He XF; Zhao JB; Chen Y; Mei QL
Cardiovasc Intervent Radiol; 2008; 31(6):1133-40. PubMed ID: 18584240
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma?
Moon WS; Rhyu KH; Kang MJ; Lee DG; Yu HC; Yeum JH; Koh GY; Tarnawski AS
Mod Pathol; 2003 Jun; 16(6):552-7. PubMed ID: 12808060
[TBL] [Abstract][Full Text] [Related]
27. Adjuvant chemotherapy with tegafur/uracil administration after transcatheter arterial chemoembolization for advanced hepatocellular carcinoma.
Ueda H; Tanaka H; Kida Y; Fukuchi H; Ichinose M
Oncol Rep; 2008 May; 19(5):1355-61. PubMed ID: 18425398
[TBL] [Abstract][Full Text] [Related]
28. Tumoral and angiogenesis factors in hepatocellular carcinoma after locoregional therapy.
Farris AB; Dursun N; Dhanasekaran R; Coban I; McIntosh EB; Adsay NV; Kim HS
Pathol Res Pract; 2012 Jan; 208(1):15-21. PubMed ID: 22088254
[TBL] [Abstract][Full Text] [Related]
29. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
[TBL] [Abstract][Full Text] [Related]
30. Tissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinoma.
Poon RT; Lau CP; Ho JW; Yu WC; Fan ST; Wong J
Clin Cancer Res; 2003 Nov; 9(14):5339-45. PubMed ID: 14614019
[TBL] [Abstract][Full Text] [Related]
31. [Expression of liver-type fatty acid-binding protein and vascular endothelial growth factor and their correlation in human hepatocellular carcinoma].
Dong LH; Li H; Wang F; Li FQ; Zhou HY; Yang HJ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):318-21. PubMed ID: 17425983
[TBL] [Abstract][Full Text] [Related]
32. [Evaluation of the effect of transcatheter arterial chemoembolization in treatment of primary hepatocellular carcinoma with magnetic resonance diffusion-weighted imaging: 4-6-week follow-up of 25 cases].
Fan WJ; Zhang L; Ouyang YS
Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(35):2474-7. PubMed ID: 19080627
[TBL] [Abstract][Full Text] [Related]
33. Effect of preoperative transcatheter arterial chemoembolization on apoptosis of hepatocellular carcinoma cells.
Xiao E; Li D; Shen S; Zhou S; Tan L; Wang Y; Luo J; Wu Y; Tan C; Liu H; Zhu H
Chin Med J (Engl); 2003 Feb; 116(2):203-7. PubMed ID: 12775230
[TBL] [Abstract][Full Text] [Related]
34. Combination therapy of transcatheter arterial chemoembolization and arterial administration of antiangiogenesis on VX2 liver tumor.
Deng G; Zhao DL; Li GC; Yu H; Teng GJ
Cardiovasc Intervent Radiol; 2011 Aug; 34(4):824-32. PubMed ID: 21671151
[TBL] [Abstract][Full Text] [Related]
35. Association between insulin-like growth factor-2 and metastases after transcatheter arterial chemoembolization in patients with hepatocellular carcinoma: a prospective study.
Song BC; Chung YH; Kim JA; Lee HC; Yoon HK; Sung KB; Yang SH; Yoo K; Lee YS; Suh DJ
Cancer; 2001 Jun; 91(12):2386-93. PubMed ID: 11413529
[TBL] [Abstract][Full Text] [Related]
36. Increased expression of vascular endothelial growth factor in small hepatocellular carcinoma.
Iavarone M; Lampertico P; Iannuzzi F; Manenti E; Donato MF; Arosio E; Bertolini F; Primignani M; Sangiovanni A; Colombo M
J Viral Hepat; 2007 Feb; 14(2):133-9. PubMed ID: 17244253
[TBL] [Abstract][Full Text] [Related]
37. [The effects of the expression of VEGF and KDR on the angiogenesis, growth and metastasis of hepatocellular carcinoma].
Zhao A; Dou K; Li K; Fu Y
Zhonghua Wai Ke Za Zhi; 2000 Jun; 38(6):453-6. PubMed ID: 11832083
[TBL] [Abstract][Full Text] [Related]
38. Role of mesohepatectomy with or without transcatheter arterial chemoembolization for large centrally located hepatocellular carcinoma.
Chen XP; Hu DY; Zhang ZW; Zhang BX; Chen YF; Zhang WG; Qiu FZ
Dig Surg; 2007; 24(3):208-13. PubMed ID: 17522469
[TBL] [Abstract][Full Text] [Related]
39. [Evaluation of transcatheter arterial chemoembolization in the prevention of postoperative recurrence in 1630 patients with hepatocellular carcinoma].
Cheng HY; Xu W; Xu AM; Chen D; Yang YF; Jia YC
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):626-8. PubMed ID: 16438876
[TBL] [Abstract][Full Text] [Related]
40. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice].
Song CC; Lu X; Cheng BB; DU J; Li B; Ling CQ
Ai Zheng; 2007 Dec; 26(12):1315-22. PubMed ID: 18076793
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]